⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 30, 2026Open Access

Nsclc_wes

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to investigate whole-exome mutation information in patients with non-small cell lung cancer.
Analysis of whole-exome mutations in 43 paired non-small cell lung cancer patients.
Identification of various mutations present in paired NSCLC samples.

Implication

Study investigates whole-exome mutations in paired samples from non-small cell lung cancer patients, highlighting genomic insights.

Abstract

This study aimed to investigate human whole-exome mutation information in 43 paired non-small cell lung cancer (NSCLC) patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

李洵(Lixun) (2026) studied this question.

synapsesocial.com/papers/6a44aedf5cd2549c8bc44091 https://doi.org/10.26036/cnp0009308

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical Interest in Exome-Based Analysis of Somatic Mutational Signatures for Non-Small Cell Lung Cancer2024 · 1 citations
2Abstract 2605: Concordance evaluation of plasma whole-exome sequencing (pWES) and tissue whole-exome sequencing (tWES): A pilot study in non-small cell lung cancer (NSCLC)Original Research · 2026
3[Whole Exome Sequencing Reveals Gene Mutation Characteristics of Primary Central Nervous System Lymphoma].2024 · 1 citations
4NSCLC_ProteomicAndRNAseqOriginal Research · 2026
5Pilot study of whole-exome sequencing and single-nucleus RNA sequencing to identify actionable alterations in cancer.Original Research · 2026

More related papers

Whole-exome ctDNA sequencing reveals intratumoral heterogeneity and drivers of relapse in locally advanced head and neck cancer2025
Abstract 5933: Whole-genome sequencing of lung neuroendocrine neoplasms reveals a <i>TP53</i> WT / <i>RB1</i> WT subtype with <i>CCND</i> amplification2026
Abstract 5062: Evaluation of genetic mutations in non-small cell lung cancer patients2024